FDA Commissioner Margaret A. Hamburg Stepping Down
Wednesday, February 11, 2015
U.S. Food and Drug Administration Commissioner, Margaret A. Hamburg, will be stepping down from her position effective March 31, 2015. She will have served as Commissioner for six years.
In a letter from Hamburg to FDA colleagues, she mentioned having “very mixed emotions” about the decision.
Some of the accomplishments that Hamburg points out include: advancing the safety and effectiveness of medical products and advancing biomedical innovation by approving novel medical products in cutting-edge areas.
Through these types of initiatives, the bioscience industry has enjoyed a cooperative relationship with Hamburg during her tenure.
Hamburg stated, “We can honestly say that our collective efforts have improved the health, safety and quality of life of the American people.”
Hamburg also shared her confidence in Dr. Stephen Ostroff who will serve as the Acting Commissioner after her departure. He joined the Agency in 2013 and most recently serving as FDA's Chief Scientist.
“I want to extend my deepest gratitude to each and every one of you for your service and for making FDA an agency that is not only an exciting and rewarding place to work, but also a place of remarkably meaningful achievement and impact on the health and well-being of Americans.” closed Hamburg’s letter.